Anemia Drugs
Publication Date
February 2024
USD 19.55 billion
USD 39.99 billion
USD 21.24 billion
Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030

[191 Pages Report] The Anemia Drugs Market size was estimated at USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024, at a CAGR 10.76% to reach USD 39.99 billion by 2030.

Anemia Drugs Market
To learn more about this report, request a free sample copy
Anemia is a medical condition characterized by a depletion in the number or quality of red blood cells, which impairs oxygen delivery to the body's tissues. Anemia drugs are agents used to treat various forms of anemia and include supplements, such as iron, folic acid, and vitamin B12, erythropoiesis-stimulating agents (ESAs), and newer therapies that target specific pathways involved in red blood cell production. Drivers for the anemia drugs adoption include a rising prevalence of anemia due to chronic diseases such as kidney failure, cancer, and diabetes; an aging population more susceptible to anemia; technological advancements in drug development; increased awareness and diagnosis rates; and improved healthcare infrastructure in emerging economies. Challenges associated with Anemia drugs comprise the high cost of novel anemia drugs, the risk of side effects and complications associated with ESAs, stringent regulatory frameworks leading to delays in drug approval, and the presence of unmet medical needs in anemia treatment, particularly for those conditions resistant to traditional therapies. The market for anemia drugs presents several opportunities, including the potential introduction of generic and biosimilar versions of ESAs due to the expiry of patents on existing products, investment in research and development of innovative treatment modalities, rising demand in developing regions, and potential expansion indications for existing products.
Anemia Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anemia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anemia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anemia Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc. by Allergan PLC, ADZO Lifesciences Pvt Ltd., Akebia Therapeutics, Inc., Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Aqunova Pharma Private Limited, Astraea Life Sciences Pvt Ltd, Bluebird Bio, Inc., Cadila Pharmaceuticals Ltd., Corona Remedies Pvt Ltd., Covis Pharma GmbH, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals Ltd., GSK PLC, Gujarat Terce Laboratories Ltd., Lupin Ltd., Pfizer Inc., Pharmacosmos A/S, Pieris Pharmaceuticals, Inc., Sanofi S.A., Solitaire Pharmacia Pvt. Ltd., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, and Triton Healthcare Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Anemia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug
    • Alglucerase Injection
    • Carbonyl Iron
    • Cyanocobalamin
    • Darbepoetin Alfa
    • Eculizumab
    • Epoetin Beta-methoxy Polyethylene Glycol
    • Ferrous FumarateIron
    • Iron Dextran
    • Iron Supplements
  • Type
    • Aplastic Anemia
    • Chronic Kidney Disease Anemia
    • Hemolytic Anemia
    • Iron Deficiency Anemia
    • Pernicious Anemia
    • Sickle Cell Anemia
    • Vitamin Deficiency Anemia
  • Route of Administration
    • Injectable
    • Oral
  • End-Users
    • Hospital
    • Self-Administered

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Anemia Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anemia Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Anemia Drugs Market?
  4. What is the market share of the leading vendors in the Anemia Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Anemia Drugs Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Anemia Drugs Market, by Drug
  7. Anemia Drugs Market, by Type
  8. Anemia Drugs Market, by Route of Administration
  9. Anemia Drugs Market, by End-Users
  10. Americas Anemia Drugs Market
  11. Asia-Pacific Anemia Drugs Market
  12. Europe, Middle East & Africa Anemia Drugs Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • AbbVie Inc. by Allergan PLC
  • ADZO Lifesciences Pvt Ltd.
  • Akebia Therapeutics, Inc.
  • Alembic Pharmaceuticals Limited
  • Alkem Laboratories Ltd.
  • Aqunova Pharma Private Limited
  • Astraea Life Sciences Pvt Ltd
  • Bluebird Bio, Inc.
  • Cadila Pharmaceuticals Ltd.
  • Corona Remedies Pvt Ltd.
  • Covis Pharma GmbH
  • Dr. Reddy's Laboratories
  • Emcure Pharmaceuticals
  • Glenmark Pharmaceuticals Ltd.
  • Gujarat Terce Laboratories Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Solitaire Pharmacia Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Triton Healthcare Pvt Ltd.
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Anemia Drugs Market
The Global Anemia Drugs Market size was estimated at USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024.
The Global Anemia Drugs Market to grow USD 39.99 billion by 2030, at a CAGR of 10.76%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.